Economy
Anthropic's IPO push includes a big bet on life sciences
Anthropic's S-1 filing says Claude can accelerate drug discovery and biology research, making life sciences central to the AI company's IPO pitch.
Publication and source
PublicationSanalda Haber
SourceBusiness Insider
Published
CategoryEconomy
Summary from the source publisher’s news feed.